Publication:
Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

dc.contributor.authorJohnson, Renee
dc.contributor.authorFletcher, Robert A
dc.contributor.authorPeters, Stacey
dc.contributor.authorOhanian, Monique
dc.contributor.authorSoka, Magdalena
dc.contributor.authorSmolnikov, Andrei
dc.contributor.authorAbihider, Katherine E
dc.contributor.authorAckerman, Michael J
dc.contributor.authorAder, Flavie
dc.contributor.authorAkhtar, Mohammed M
dc.contributor.authorAmin, Ahmad S
dc.contributor.authorAshley, Euan A
dc.contributor.authorAtherton, John J
dc.contributor.authorAustin, Rachel
dc.contributor.authorBaas, Annette F
dc.contributor.authorBagnall, Richard D
dc.contributor.authorRoss, Samantha Barratt
dc.contributor.authorBlouin, Jean-Louis
dc.contributor.authorBrown, Emily E
dc.contributor.authorBundgaard, Henning
dc.contributor.authorCannie, Douglas
dc.contributor.authorChmielewski, Przemyslaw
dc.contributor.authorCorrenti, Gemma
dc.contributor.authorCrespo-Leiro, Maria Generosa
dc.contributor.authorDal Ferro, Matteo
dc.contributor.authorDellefave-Castillo, Lisa M
dc.contributor.authorDominguez, Fernando
dc.contributor.authorDooijes, Dennis
dc.contributor.authorDybro, Anne M
dc.contributor.authorEd Demri, Youssef
dc.contributor.authorEl Hachmi, Mohamed
dc.contributor.authorEscobar-Lopez, Luis
dc.contributor.authorFoye, Sarah Jajesnica
dc.contributor.authorFranaszczyk, Maria
dc.contributor.authorGigli, Marta
dc.contributor.authorLopez, Esther Gonzalez
dc.contributor.authorGoudal, Adeline
dc.contributor.authorGraw, Sharon
dc.contributor.authorGuipponi, Michel
dc.contributor.authorHaan, Eric
dc.contributor.authorHaas, Jan
dc.contributor.authorHammersley, Daniel J
dc.contributor.authorHansen, Frederikke G
dc.contributor.authorHayward, Christopher S
dc.contributor.authorHey, Thomas Morris
dc.contributor.authorHeymans, Stephane
dc.contributor.authorHo, Carolyn Y
dc.contributor.authorHouweling, Arjan C
dc.contributor.authorIngles, Jodie
dc.contributor.authorIngrey, Angela
dc.contributor.authorJabbour, Andrew
dc.contributor.authorJames, Paul A
dc.contributor.authorJansweijer, Joeri A
dc.contributor.authorJongbloed, Jan D H
dc.contributor.authorKeogh, Anne M
dc.contributor.authorLarrañaga-Moreira, Jose M
dc.contributor.authorLekanne Deprez, Ronald H
dc.contributor.authorMacciocca, Ivan
dc.contributor.authorMacdonald, Peter S
dc.contributor.authorMansencal, Nicolas
dc.contributor.authorMansour, Julia
dc.contributor.authorMartinez-Veira, Cristina
dc.contributor.authorMcDonough, Barbara
dc.contributor.authorMcGaughran, Julie
dc.contributor.authorMedo, Kristen
dc.contributor.authorMerlo, Marco
dc.contributor.authorMichalak, Ewa
dc.contributor.authorMonserrat, Lorenzo
dc.contributor.authorMountain, Helen
dc.contributor.authorMuller, Steven A
dc.contributor.authorMurphy, Anne M
dc.contributor.authorMurray, Brittney
dc.contributor.authorOates, Emily C
dc.contributor.authorOrmondroyd, Elizabeth
dc.contributor.authorPachter, Nicholas
dc.contributor.authorPaldino, Alessia
dc.contributor.authorPalmyre, Aurélien
dc.contributor.authorPereira, Naveen L
dc.contributor.authorPicard, Kermshlise C
dc.contributor.authorPoplawski, Nicola
dc.contributor.authorPrasad, Sanjay
dc.contributor.authorProukhnitzky, Julie
dc.contributor.authorPruny, Jean-Francois
dc.contributor.authorReant, Patricia
dc.contributor.authorRichard, Pascale
dc.contributor.authorRonan, Anne
dc.contributor.authorSedaghat-Hamedani, Farbod
dc.contributor.authorSemsarian, Christopher
dc.contributor.authorStorm, Garrett
dc.contributor.authorStroeks, Sophie
dc.contributor.authorSyrris, Petros
dc.contributor.authorTaylor, Matthew R G
dc.contributor.authorThomson, Kate
dc.contributor.authorThompson, Tina
dc.contributor.authorvan Tintelen, J Peter
dc.contributor.authorVissing, Christoffer Rasmus
dc.contributor.authorWaddell-Smith, Kathryn E
dc.contributor.authorWallis, Mathew
dc.contributor.authorZentner, Dominica
dc.contributor.authorArnott, Clare
dc.contributor.authorMarian, Ali J
dc.contributor.authorOh, Jaewon
dc.contributor.authorFokstuen, Siv
dc.contributor.authorJames, Cynthia A
dc.contributor.authorBarriales-Villa, Roberto
dc.contributor.authorMeder, Benjamin
dc.contributor.authorWahbi, Karim
dc.contributor.authorGiudicessi, John R
dc.contributor.authorParikh, Victoria N
dc.contributor.authorWare, James S
dc.contributor.authorPiriou, Nicolas
dc.contributor.authorRooryck, Caroline
dc.contributor.authorLakdawala, Neal K
dc.contributor.authorMestroni, Luisa
dc.contributor.authorSinagra, Gianfranco
dc.contributor.authorElliott, Perry M
dc.contributor.authorWatkins, Hugh
dc.contributor.authorMcNally, Elizabeth M
dc.contributor.authorCharron, Philippe
dc.contributor.authorvan Spaendonck-Zwarts, Karin Y
dc.contributor.authorGarcia-Pavia, Pablo
dc.contributor.authorPeña-Peña, Maria Luisa
dc.contributor.authorMogensen, Jens
dc.contributor.authorChristensen, Alex Hoerby
dc.contributor.authorBilińska, Zofia T
dc.contributor.authorRasmussen, Torsten B
dc.contributor.authorSeidman, Jonathan G
dc.contributor.authorSeidman, Christine E
dc.contributor.authorTe Riele, Anneline S J M
dc.contributor.authorVerdonschot, Job A J
dc.contributor.authorPinto, Yigal M
dc.contributor.authorChristiaans, Imke
dc.contributor.authorFatkin, Diane
dc.date.accessioned2026-04-20T09:07:56Z
dc.date.available2026-04-20T09:07:56Z
dc.date.issued2025-12-22
dc.description.abstractTruncating variants in the TTN gene (TTNtv) are the most common genetic cause of dilated cardiomyopathy (DCM) but also occur as incidental findings in the general population. This study investigated factors associated with the clinical manifestation of TTNtv. An international multicentre retrospective observational study was performed in families with TTNtv-related DCM. Shared frailty models were used to estimate associations of variant characteristics with lifetime risk of DCM, and logistic regression to estimate odds ratios (ORs) for individual-level clinical risk factor profiles (cardiac conditions, cardiovascular comorbidities, lifestyle) and DCM. A total of 3158 subjects in 1043 families with TTNtv-related DCM were studied. TTNtv-positive subjects were 21-fold more likely to develop DCM [OR, 21.21; 95% confidence interval (CI), 14.80-30.39]. Disease onset was earlier in males, but was similar for TTNtv of different types and locations. The presence of clinical risk factors was associated with earlier DCM onset (OR, 3.41; 95% CI, 2.06-5.64), with a prior history of atrial fibrillation having a two-fold increased odds of DCM (OR, 2.05; 95% CI, 1.27-3.32). The prevalence of clinical risk factors increased with age; however, the strength of the DCM association was greatest for young-onset (<30 years) disease (OR, 4.75; 95% CI, 2.35-9.60). Administration of beta-adrenergic receptor or renin-angiotensin system-blocking drugs prior to overt DCM was associated with 87% reduced odds of DCM (OR, .13; 95% CI, .08-.23). Disease onset in TTNtv-associated familial DCM is dependent on individual patient context and is potentially modifiable by risk factor management and prophylactic therapeutic intervention.
dc.description.peerreviewed
dc.description.tableofcontentsR.A.F. acknowledges the receipt of studentship awards from the Health Data Research UK-Alan Turing Institute Wellcome Trust PhD Programme in Health Data Science (218529/Z/19/Z). S. Peters receives funding from the Royal Melbourne Hospital Victor Hurley Medical Research Grant, Melbourne Health. A.S. and E.C.O. receive funding from the Australian Government Medical Research Futures Fund (MRFF) (2016906, 2025450). R.D.B. is the recipient of a Cardiovascular Disease Senior Scientist Grant from New South Wales Health. D.C. receives funding from British Heart Foundation Clinical Research Training Fellowship (FS/CRTF/20/24022). P. Chmielewski and Z.T.B. received funding from European Research Area Network on Cardiovascular Diseases Joint Transnational Call 2016 (DETECTIN-HF). M.G.C.L. receives grant support from CIBERCV. L.M.D.C. receives support from the National Institutes of Health ([NIH]; HL128075, HL131914, HG008673), and American Heart Association SFRN. F.D. received support from Instituto de Salud Carlos III (PI20/0320). S.H. has received research funding from the European Commission Innovative Medicines Initiative 2 (CARDIATEAM, 821508), European Union Commission’s Seventh Framework programme (HOMAGE, 305507), HORIZON European Innovation Council / European Commission Pathfinder Challenges 2022: Cardiogenomics (DCM NEXT; 101115416), Dutch Research Council Open Call ZonMW-Metacor; Member of the European Reference Network for rare low prevalence and complex diseases of the heart-ERN GUARD-Heart. C.Y.H. receives research funding from NIH/National Heart Lung and Blood Institute (R01HL155568). J.I. is the recipient of a Future Leader Fellowship from National Heart Foundation of Australia (106732). A.J. receives funding from New South Wales Health, St Vincent’s Clinic Foundation. P.S.M. receives grant support from the National Health and Medical Research Council (NHMRC) and the Australian Government MRFF. B. McDonagh receives funding from the Howard Hughes Medical Institute. S. Prasad receives funding from the British Heart Foundation and Myocarditis UK. C.S. is the recipient of an NHMRC Investigator Grant (2016822) and a Cardiovascular Disease Clinician Scientist Grant from New South Wales Health. M.R.G.T. and L. Mestroni receive grant support from the NIH (X01 HL139403, UL1 RR025870, R01HL164634, R01HL147064, R01HL170012). D.Z. holds a DW Keir Fellowship in Medical Research 2022–2024. C.A. holds an MRFF Investigator Grant, and receives grant support from New South Wales Health and NHMRC Clinical Trials and Cohort Studies Grant. A.J.M. receives funding from the NIH/National Heart, Lung and Blood Institute (R01 HL151737, R01 HL132401) and National Institute on Aging (R01AG082751). R.B.V. receives funding from Health in Code, Bristol Myers Squibb and Sanofi. B. Meder receives funding from Translational Genomics and Epigenomics of Cardiomyopathies & Heart Failure, Bundesministerium fur Forschung und Technologie, Informatics for Life (KTS-Foundation), Digital Heart Medicine 4.0, Support Informatics for Life, Professorship (MWK), Cardiac Splicing as a Therapeutic Target (Leducq-Foundation). V.N.P. receives funding from Career Development Awards (John Taylor Babbitt Foundation, Sarnoff Cardiovascular Research Foundation) and NIH (K08 HL143185, NIH R01 HL168059-03). J.S.W. receives grant support from Sir Jules Thorn Charitable Trust, Medical Research Council UK, NIHR Imperial BRC, British Heart Foundation, Bristol Myers Squibb (105516) and Pfizer. H.W. receives funding from the British Heart Foundation’s Big Beat Challenge award, CureHeart (BBC/F/21/220106). E.M.M. receives funding from the NIH and the American Heart Association. P. Charron receives funding from National Agency for Research (ANR, ANR-16-ECVD-0010). P.G.P., A.S.A. and P. Charron are funded by the HORIZON European Innovation Council/European Commission Pathfinder Challenge 2022: Cardiogenomics (DCM-NEXT project; project 101115416); The CNIC is supported by the Instituto de Salud Carlos III, MCIN, the Pro-CNIC Foundation, and the Severo Ochoa Centers of Excellence program (CEX2020-001041-S); The Hospital Universitario Puerta de Hierro, is the member of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart. C.E.S. and J.G.S. received funding from the British Heart Foundation’s Big Beat Challenge, CureHeart (BBC/F/21/220106), the Choudhrie Family fund and NIH (5R01HL080494, 5R01HL084553). C.E.S. also received funding from the Howard Hughes Medical Institute. A.S.J.M.R. is supported by ZonMW grants (2021 Off Road FUEL-cardiomyopathy and 2024 Clinical Fellows Gene-First). J.A.J.V is supported by the Hartstichting Dekker Clinical Scientist grant. Australian Genomics is funded by NHMRC (GNT1113531, GNT2000001 and GNT2035846). D.F. receives funding from New South Wales Health, National Heart Foundation of Australia (105516), and the Australian Government MRFF (2017687).
dc.identifier.citationEur Heart J. 2025 Dec 22;46(48):5240-5257.
dc.identifier.journalEUROPEAN HEART JOURNAL
dc.identifier.pubmedID40796136
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27434
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1093/eurheartj/ehaf380
dc.repisalud.institucionCNIC
dc.rights.accessRightsopen access
dc.subjectDilated cardiomyopathy
dc.subjectGenetics
dc.subjectPrevention
dc.subjectRisk factors
dc.subjectTitin
dc.titleTitin-related familial dilated cardiomyopathy: factors associated with disease onset.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Titin-related familial dilated cardiomyopathy_Eur Heart J_2025.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format